Updated review on the benefits of weight loss
The DOI matches its Crossref record.
Abstract
Obesity is associated with type 2 diabetes, hypertension and hyperlipidaemia. Modest weight loss has been shown to have a beneficial effect on these cardiovascular risk factors and to improve risk factor clustering. Recent lifestyle intervention studies also suggest that modest weight loss can help to prevent two of the most common conditions associated with obesity: hypertension and type 2 diabetes. The practical problem is how to translate results from these studies into daily practice. In the studies, only a limited number of individuals maintained substantial weight loss over the follow up period. New approaches are needed to achieve and maintain weight loss.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity induces insulin resistance, mediated by chronic low-grade inflammation including endoplasmic reticulum (ER) stress, mitochondrial dysfunction, and hyperinsulinemia secondary to diminished insulin excretion via the kidney and the liver along with increased insulin production resulting from the increased number of pancreatic beta-cells”
In the citing paper
“weight loss is reported to attenuate or reverse obesity-induced insulin resistance [48,49]”
Citations
Cited by
Wing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2415 · Cited by 1,828
Klein, S., Sheard, N. F., Pi-Sunyer, X., Daly, A., Wylie-Rosett, J., Kulkarni, K., & Clark, N. G. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2067 · Cited by 540
A comprehensive view of sex-specific issues related to cardiovascular disease
Pilote, L., Dasgupta, K., Guru, V., Humphries, K. H., McGrath, J., Norris, C., Rabi, D., Tremblay, J., Alamian, A., Barnett, T., et al. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.051455 · Cited by 476
“25 kg over 16 years had a 40%–50% reduction in their total cardiovascular risk factor score.(127) Independent of its impact on weight, regular exercise has favourable effects on glucose control, blood pressure, serum lipids and fitness levels.”
Weinheimer, E. M., Sands, L. P., & Campbell, W. W. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00298.x · Cited by 391
Barte, J. C. M., Ter Bogt, N. C. W., Bogers, R. P., Teixeira, P. J., Blissmer, B., Mori, T. A., & Bemelmans, W. J. E. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00740.x · Cited by 319
Diagnosis and Treatment of Subclinical Hypercortisolism
Chiodini, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2722 · Cited by 279
“The improvement or worsening of body weight should be defined by a greater than 5–10% decrease or increase, respectively (104).”
BackgroundKlein, S., Sheard, N. F., Pi-Sunyer, X., Daly, A., Wylie-Rosett, J., Kulkarni, K., & Clark, N. G. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.2.257 · Cited by 275
Fatouros, I. G., Tournis, S., Leontsini, D., Jamurtas, A. Z., Sxina, M., Thomakos, P., Manousaki, M., Douroudos, I., Taxildaris, K., & Mitrakou, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0261 · Cited by 249
“Marked weight loss (21%) after gastric partition surgery caused a 46% increase in serum adiponectemia (58).”
BackgroundKim, J. E., O’Connor, L. E., Sands, L. P., Slebodnik, M. B., & Campbell, W. W. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuv065 · Cited by 238
Long-term follow-up in adrenal incidentalomas: an Italian multicenter study
Morelli, V., Reimondo, G., Giordano, R., Della Casa, S., Policola, C., Palmieri, S., Salcuni, A. S., Dolci, A., Mendola, M., Arosio, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3527 · Cited by 223
“a Body weight is considered improved or worsened in the presence of at least a 5% variation with respect to baseline (37).”
Stein, N., & Brooks, K. (2017) · JMIR Diabetes · doi:10.2196/diabetes.8590 · Cited by 191
“Modest weight loss among overweight individuals also improves glycemic control [7-10].”
BackgroundChoi, Y. J., Jeon, S.-M., & Shin, S. (2020) · Nutrients · doi:10.3390/nu12072005 · Cited by 193
Chiodini, I., Morelli, V., Salcuni, A. S., Eller-Vainicher, C., Torlontano, M., Coletti, F., Iorio, L., Cuttitta, A., Ambrosio, A., Vicentini, L., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2387 · Cited by 191
“The improvement or worsening of body weight was defined by a greater than 5% decrease or increase of body weight (37), respectively, between baseline and the end of the follow-up period.”
BackgroundValsamakis, G., McTernan, P. G., Chetty, R., Al Daghri, N., Field, A., Hanif, W., Barnett, A. H., & Kumar, S. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.022 · Cited by 189
Aronne, L., Fujioka, K., Aroda, V., Chen, K., Halseth, A., Kesty, N. C., Burns, C., Lush, C. W., & Weyer, C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2003 · Cited by 178
“Because even moderate weight loss (5%) can reportedly attenuate the risk of obesity related comorbidities such as diabetes, cardiovascular disease, and dyslipidemia (23, 24), one standard efficacy criterion for pharmacological weight loss trials is the proportion of subjects achieving a reduction of 5% of initial body…”
BackgroundAn integrated method to determine meaningful changes in health-related quality of life
Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.04.004 · Cited by 165
Zhou, C., Wang, M., Liang, J., He, G., & Chen, N. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610429 · Cited by 151
“Bo weight control is consid red an effective interventio strat gy for attenuating nsulin resistan e induce by obesity [27,28].”
BackgroundEffects on cardiovascular risk factors of weight losses limited to 5–10 %
Brown, J. D., Buscemi, J., Milsom, V., Malcolm, R., & O’Neil, P. M. (2016) · Translational Behavioral Medicine · doi:10.1007/s13142-015-0353-9 · Cited by 145
Kopelman, P., Bryson, A. L., Hickling, R. I., Rissanen, A., Rössner, S., Toubro, S., & Valensi, P. E. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803446 · Cited by 156
Central control of thermogenesis
Clapham, J. C. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.014 · Cited by 140
“It should be emphasised that there are clear health benefits to weight loss, even relatively modest weight loss (Vidal, 2002) and could be related, to a certain extent, to the decrease in SNS activity to cardiovascular tissue.”
Adipose tissue macrophages: Unique polarization and bioenergetics in obesity
Caslin, H. L., Bhanot, M., Bolus, W. R., & Hasty, A. H. (2020) · Immunological Reviews · doi:10.1111/imr.12853 · Cited by 134
“Future work should define (1) if the hypermetabolic phenotype is a result of pooled populations or if it is present in single populations and (2) how obese ATMs use glycolysis and OX PHOS for energy production, intermediate mediators, and both phagocytic and inflammatory functions.”
BackgroundThe Healthy Lifestyle Change Program
Bazzano, A., Zeldin, A. S., Diab, I. R. S., Garro, N., Allevato, N. A., & Lehrer, D. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2009.08.005 · Cited by 119
Cabergoline for Cushing’s disease: a large retrospective multicenter study
Ferriere, A., Cortet, C., Chanson, P., Delemer, B., Caron, P., Chabre, O., Reznik, Y., Bertherat, J., Rohmer, V, Briet, C., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0662 · Cited by 115
Weight regaining: From statistics and behaviors to physiology and metabolism
Anastasiou, C. A., Karfopoulou, E., & Yannakoulia, M. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.006 · Cited by 119
González-Campoy, J. M., Jeor, S. T. S., CASTORINO, K. N., Ebrahim, A., Hurley, D., Jovanovič, L., Mechanick, J. I., Petak, S. M., Yu, Y., Harris, K. A., et al. (2013) · Endocrine Practice · doi:10.4158/ep13155.esgl · Cited by 103
González-Campoy, J. M., CASTORINO, K. N., Ebrahim, A., Hurley, D., Jovanovič, L., Mechanick, J. I., Petak, S. M., Yu, Y., Jeor, S. T. S., Harris, K. A., et al. (2013) · Endocrine Practice · doi:10.4158/ep13155.gl · Cited by 154
Healthy Behavior Change of Adults With Mental Retardation: Attendance in a Health Promotion Program
Mann, J. R., Zhou, H., McDermott, S. W., & Poston, M. B. (2005) · American Journal on Mental Retardation · doi:10.1352/0895-8017(2006)111[62:hbcoaw]2.0.co;2 · Cited by 99
Lindahl, B., Nilssön, T. K., Borch-Johnsen, K., Røder, M. E., Söderberg, S., Widman, L., Johnson, O., Hallmans, G., & Jansson, J.-H. (2009) · Scandinavian Journal of Public Health · doi:10.1177/1403494808101373 · Cited by 87
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity
Anandhakrishnan, A., & Korbonits, M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i20.572 · Cited by 82
Mao, A. Y., Chen, C., Magana, C., Caballero Barajas, K., & Olayiwola, J. N. (2017) · JMIR mHealth and uHealth · doi:10.2196/mhealth.7591 · Cited by 77
“Weight loss as modest as 5% total body weight in people with a body mass index (BMI) over 25 kg/m(2) can significantly improve glycosylated hemoglobin, blood pressure, and hyperlipidemia, and can reduce the progression of hypertension and diabetes [7-9].”
BackgroundDoes weight cycling promote obesity and metabolic risk factors?
Mackie, G. M., Samocha‐Bonet, D., & Tam, C. S. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2016.10.284 · Cited by 86
Weight cycling induces innate immune memory in adipose tissue macrophages
Caslin, H. L., Cottam, M. A., Pinon, J., Boney, L. Y., & Hasty, A. H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.984859 · Cited by 89
The long‐term effect of energy restricted diets for treating obesity
Langeveld, M., & DeVries, J. H. (2015) · Obesity · doi:10.1002/oby.21146 · Cited by 73
“Changes in carbohydrate and fat metabolism and blood pressure regulation that underlie this increased risk are, at least partly, reversible through weight loss, resulting in positive changes in blood pressure, fasting blood glucose, and lipid profile (2).”
BackgroundPuhkala, J., Kukkonen-Harjula, K., Mansikkamäki, K., Aittasalo, M., Hublin, C., Kärmeniemi, P., Olkkonen, S., Partinen, M., Sallinen, M., Tokola, K., et al. (2015) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.3463 · Cited by 73
Eller-Vainicher, C., Morelli, V., Salcuni, A. S., Battista, C., Torlontano, M., Coletti, F., Iorio, L., Cairoli, E., Beck-Peccoz, P., Arosio, M., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0602 · Cited by 73
Perioperative management of the post–gastric-bypass patient presenting for body contour surgery
Rubin, J. P., Nguyen, V. T., & Schwentker, A. R. (2004) · Clinics in Plastic Surgery · doi:10.1016/j.cps.2004.03.017 · Cited by 72
“Most importantly, it provides durable weight loss, which can lead to improvement and even resolution of many comorbid illnesses [2–6].”
BackgroundMazokopakis, E. E., Papadomanolaki, M. G., Fousteris, A. A., Kotsiris, D. A., Lampadakis, I., & Ganotakis, E. S. (2014) · PubMed Central · Cited by 89
Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes
Pullman, J. R., Darsow, T., & Frías, J. P. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.203 · Cited by 69
“Vascular Health and Risk Management 2006:2(3)208 Furthermore, obesity increases cardiovascular risk due to effects on blood pressure and lipids (Alexander 2001; Vidal 2002) and also appears to have effects independent of these established risk factors (Yan et al 2006).”
BackgroundInfluentialThe new era of drug therapy for obesity: the evidence and the expectations
Jones, B. J., & Bloom, S. R. (2015) · Drugs · doi:10.1007/s40265-015-0410-1 · Cited by 58
“A reduction in body weight of 5–10 % is enough for significant improvements in cardiovascular risk factor profiles [28–32], kidney disease [33] and osteoarthritis [34].”
BackgroundMorelli, V., Frigerio, S., Aresta, C., Passeri, E., Pugliese, F., Copetti, M., Barbieri, A. M., Fustinoni, S., Polledri, E., Corbetta, S., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.898084 · Cited by 68
“number of antihypertensive drugs was at least halved or doubled, respectively; (iii) for glycometabolic control, if glucose levels passed from a category to another, following the ADA criteria, or if the dosage of antidiabetic drugs was at least halved or doubled, respectively, or if an antidiabetic drug was withdrawn…”
BackgroundSjöholm, K., Palming, J., Lystig, T., Jennische, E., Woodruff, T. K., Carlsson, B., & Carlsson, L. M. S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.030 · Cited by 66
Obese patients have higher circulating protein levels of dipeptidyl peptidase IV
Stengel, A., Goebel‐Stengel, M., Teuffel, P., Hofmann, T., Buße, P., Kobelt, P., Rose, M., & Klapp, B. F. (2014) · Peptides · doi:10.1016/j.peptides.2014.09.006 · Cited by 65
Meta-analysis of the effect of exercise programs for individuals with intellectual disabilities
Shin, I., & Park, E. (2012) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2012.05.019 · Cited by 62
Esfahani, A., Wong, J. M. W., Mirrahimi, A., Villa, C. R., & Kendall, C. W. C. (2011) · IUBMB Life · doi:10.1002/iub.418 · Cited by 56
“Second, evidence suggests that weight maintenance is crucial for sustaining the physiological benefits associated with a reduction in weight (42).”
BackgroundEdholm, D., Kullberg, J., Karlsson, F. A., Haenni, A., Ahlström, H. K., & Sundbom, M. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.07.018 · Cited by 55
“Modest weight loss is associated with health benefits with regard to hypertension and hyperlipidemia [15], and as LCD represents a major diet change, this is beneficial regarding blood lipids, which others have noted [16].”
BackgroundKaholokula, J. K., Mau, M. K., Efird, J. T., Leake, A., West, M., Palakiko, D.-M., Yoshimura, S. R., Kekauoha, B. P., Rose, C., & Gomes, H. (2012) · Health Education & Behavior · doi:10.1177/1090198110394174 · Cited by 55
“There are many health benefits to losing excess weight and keeping it off for people who are overweight and obese, such as improving blood pressure, physical functioning, and diabetes management, if not its prevention (Knowler et al., 2009; Martin et al., 2001; Norris et al., 2005; Vidal, 2002).”
BackgroundMcConnon, Á., Raats, M. M., Astrup, A. V., Bajzová, M., Handjieva‐Darlenska, T., Lindroos, A. K., Martínez, J. A., Larsen, T. M., Papadaki, A., Pfeiffer, A. F. H., et al. (2011) · Appetite · doi:10.1016/j.appet.2011.10.017 · Cited by 68
“The benefits of weight loss and weight loss maintenance have been well documented (Vidal, 2002).”
BackgroundKitson, S., Lindsay, J., Sivalingam, V. N., Lunt, M., Ryan, N. A. J., Edmondson, R. J., Rutter, M. K., & Crosbie, E. J. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.11.019 · Cited by 63
“Weight loss, with its favorable impact on insulin resistance, blood pressure and cholesterol profiles, particularly given its low cost, low risk of harm, and added benefits for quality of life is the obvious answer [25,26], but one that is very difficult to achieve and sustain by dietary restriction and lifestyle chan…”
BackgroundUsing Avatars to Model Weight Loss Behaviors: Participant Attitudes and Technology Development
Napolitano, M. A., Hayes, S., Russo, G., Muresu, D., Giordano, A., & Foster, G. D. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700430 · Cited by 51
“low-calorie items, (2) physical activity, (3) portion sizes, and (4) stimulus control.”
The Role of Pramlintide for Weight Loss
Dunican, K. C., Adams, N. M., & Desilets, A. R. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m210 · Cited by 50
Gibbs, B. B., Brancati, F. L., Chen, H., Coday, M., Jakicic, J. M., Lewis, C. E., Stewart, K. J., Clark, J. M., & (for the Look AHEAD Research Group) (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487312462823 · Cited by 48
“Individuals with type 2 diabetes (T2DM) are at increased risk for cardiovascular disease, and weight loss is known to improve cardiovascular risk factors including hypertension, glycaemia, and hyperlipidaemia.(1) Yet, risk factor improvement with weight loss varies considerably across individuals.”
BackgroundMedications as Adjunct Therapy for Weight Loss: Approved and Off-Label Agents in Use
Moyers, S. B. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2005.03.010 · Cited by 56
Hussey, E. K., Dobbins, R. L., Stoltz, R. R., Stockman, N. L., O'Connor‐Semmes, R. L., Kapur, A., Murray, S. C., Layko, D., & Nunez, D. J. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009352185 · Cited by 47
“Weight loss is an important therapeutic goal for the overweight or obese patient because it improves glycemic control and reduces cardiovascular risk; even a modest loss of 5% of body weight can produce significant health benefits.(20,21) Our study indicates that overweight and obese subjects may achieve appreciable r…”
BackgroundA Return-on-Investment Simulation Model of Workplace Obesity Interventions
Trogdon, J. G., Finkelstein, E. A., Reyes, M., & Dietz, W. H. (2009) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3181a86656 · Cited by 51
“Evidence suggests that among obese individuals, weight loss of 5% to 10% of body weight from baseline reduces the risk and complications of type 2 diabetes, hypertension, hyperlipidemia, and other conditions.(7,8) Table 1 presents estimated cost savings as a function of the percentage of baseline weight lost for each…”
BackgroundEthnic-Specific Weight-Loss Interventions for Low-Income Postpartum Women
Walker, L. O., Sterling, B. S., Latimer, L. A., Kim, S., García, A. A., & Fowles, E. R. (2011) · Western Journal of Nursing Research · doi:10.1177/0193945911403775 · Cited by 45
“Conversely, even modest weight losses (5%-10%) have been shown to have beneficial health effects (Vidal, 2002).”
BackgroundMethodInfluentialLifestyle, family history and progression of hypertension
Winnicki, M., Somers, V. K., Dorigatti, F., Longo, D., Santonastaso, M., Mos, L., Mattarei, M., Pessina, A. C., & Palatini, P. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000239281.27938.d4 · Cited by 44
Is weight cycling associated with adverse health outcomes? A cohort study
Madigan, C. D., Pavey, T., Daley, A., Jolly, K. B., & Brown, W. J. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.12.010 · Cited by 49
“However losing at least 5% of initial body weight is associated with improvements in glycaemic control, blood pressure, triglycerides and HDL cholesterol (Van Gaal, Mertens, & Ballaux, 2005; Vidal, 2002; Wing & Hill, 2001; Wing et al., 2011).”
BackgroundCiciurkaite, G., Moloney, M. E., & Brown, R. L. (2019) · Public Health Reports · doi:10.1177/0033354918813102 · Cited by 40
Dasgupta, K., Hajna, S., Joseph, L., Da Costa, D., Christopoulos, S., & Gougeon, R. (2012) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/1479-5868-9-125 · Cited by 32
“A net weight loss of 5% or more leads to improvements in both blood pressure and glycemia, [2-6] and there is even evidence for improvements with net weight loss of as little as 2 to 5% in persons with”
BackgroundA family-based education program for obesity: a three-year study
Tanas, R., Marcolongo, R., Pedretti, S., & Gilli, G. (2007) · BMC Pediatrics · doi:10.1186/1471-2431-7-33 · Cited by 40
“In this view, a steady weight loss, ranging from 5 to 10% [14,15] and lasting for at least two years, is associated with significant health benefits and is generally considered a good therapeutic result.”
Backgroundvan Wier, M. F., Dekkers, J. C., Hendriksen, I. J. M., Heymans, M. W., Ariëns, G. A. M., Pronk, N. P., Smid, T., & van Mechelen, W. (2011) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0b013e31821f2bbb · Cited by 39
Who responds to financial incentives for weight loss? Evidence from a randomized controlled trial
Paloyo, A. R., Reichert, A. R., Reuss-Borst, M. A., & Tauchmann, H. (2015) · Social Science & Medicine · doi:10.1016/j.socscimed.2015.09.034 · Cited by 48
“…loses, say, at least 1 kg is an attractive proposition, it is not necessarily better than increasing the likelihood of a particular group of people to lose at least 5 percent of their current weight, which is often regarded as a threshold to improve the health status of the obese [Vidal 2002].”
Comparison of Efficacy of Sibutramine or Orlistat Versus Their Combination in Obese Women
Sari, R., Balci, M. K., Cakir, M., Altunbas, H., & Karayalcin, U. (2004) · Endocrine Research · doi:10.1081/erc-200027356 · Cited by 39
“Most studies on the effects of weight loss on blood pressure do not distinguish between acute or continuing weight loss and steady-state weight maintenance after weight loss (16,17).”
BackgroundBrixner, D. I., McAdam‐Marx, C., Ye, X., Boye, K. S., Nielsen, L. L., Wintle, M., Misurski, D., & Fabunmi, R. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01081.x · Cited by 38
Rossi, F. E., Lira, F. S., Silva, B. S. D. A., Freire, A. P. C. F., Ramos, E. M. C., & Gobbo, L. A. (2018) · Aging Clinical and Experimental Research · doi:10.1007/s40520-018-1029-3 · Cited by 42
Koh, J., Song, K., Kwak, M. K., Suh, S., Kim, B., Sung, T., Hong, J. H., Jeong, B. C., Kim, J. H., & Lee, S. H. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000006183 · Cited by 44
Hatchett, P. E., Mulroy, S. J., Eberly, V. J., Haubert, L. L., & Requejo, P. S. (2016) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2015.1133482 · Cited by 41
Finkelstein, E. A., Tham, K. W., Haaland, B. A., & Sahasranaman, A. (2017) · Social Science & Medicine · doi:10.1016/j.socscimed.2017.05.030 · Cited by 40
Managing Obesity in Primary Care: Breaking Down the Barriers
Forgione, N., Deed, G., Kilov, G., & Rigas, G. (2018) · Advances in Therapy · doi:10.1007/s12325-017-0656-y · Cited by 43
“Elaborate on the health benefits of weight loss [12].”
BackgroundTarget Value of Intraabdominal Fat Area for Improving Coronary Heart Disease Risk Factors
Tanaka, K., Okura, T., Shigematsu, R., Nakata, Y., Lee, D. J., Wee, S. W., & Yamabuki, K. (2004) · Obesity Research · doi:10.1038/oby.2004.81 · Cited by 35
Go Big or Go Home: Obesity and Total Joint Arthroplasty
Blankstein, M., Browne, J. A., Sonn, K. A., Ashkenazi, I., & Schwarzkopf, R. M. (2023) · The Journal of Arthroplasty · doi:10.1016/j.arth.2023.07.001 · Cited by 34
Astre, G., Deleruyelle, S., Dortignac, A., Bonnet, C. B., Valet, P., & Dray, C. (2018) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-018-0650-0 · Cited by 38
Dilla, T., Valladares, A., Nicolay, C., Salvador, J., Reviriego, J., & Costi, M. P. (2012) · Applied Health Economics and Health Policy · doi:10.1007/bf03261876 · Cited by 33
Carls, G. S., Goetzel, R. Z., Henke, R. M., Bruno, J. A., Isaac, F. W., & McHugh, J. (2010) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e31820451fd · Cited by 32
Impaired HDL function in obese adolescents: Impact of lifestyle intervention and bariatric surgery
Matsuo, Y., Oberbach, A., Till, H., Inge, T. H., Wabitsch, M., Moß, A., Jehmlich, N., Völker, U., Müller, U., Siegfried, W., et al. (2013) · Obesity · doi:10.1002/oby.20538 · Cited by 35
“Only a limited number of individuals succeeded in maintaining substantial weight loss over time (29).”
BackgroundYoong, S. L., Carey, M. L., Sanson‐Fisher, R., & D’Este, C. A. (2012) · BMC Family Practice · doi:10.1186/1471-2296-13-48 · Cited by 33
“; licensee BioMed Central Commons Attribution License (http://creativec reproduction in any medium, provided the or that weight reductions of five to 10% of baseline body weight in those who are obese can reduce the risk of diabetes and improve clustering of cardiovascular disease related risk factors [5].”
BackgroundPeltzer, K., & Pengpid, S. (2014) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2014.08.004 · Cited by 31
“Weight loss or reduction is an essential interention in obesity [2] which can reduce health risks ssociated with chronic diseases [3].”
BackgroundTargeting thermogenesis and related pathways in anti-obesity drug discovery
Clapham, J. C., & Arch, J. R. S. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.04.004 · Cited by 32
“Encouragingly, even modest weight loss is associated with significant metabolic benefits (Vidal, 2002), though this doesn't always provide comfort to the patient who wants to see significantly noticeable effects on body weight and shape.”
BackgroundStengel, A., Goebel‐Stengel, M., Wang, L., Hu, E., Karasawa, H., Pisegna, J. R., & Taché, Y. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00598.2012 · Cited by 37
Burroughs, V. J., Nonas, C., Sweeney, C. T., Rohay, J. M., Harkins, A. M., Kyle, T. K., & Burton, S. L. (2008) · Obesity · doi:10.1038/oby.2008.61 · Cited by 33
Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes
Schnabel, C. A., Wintle, M. E., & Kolterman, O. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.1.69 · Cited by 32
“%) markedly improves glycemic control in patients with type 2 diabetes and reduces the severity of vascular risk factors and comorbidities (Goldstein 1992; Williamson et al 2000; Vidal 2002).”
BackgroundThe effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss
Rowe, R., Cowx, M., Poole, C., McEwan, P., Morgan, C., & Walker, M. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x74943 · Cited by 28
Early Decreases in Plasma Lipid Transfer Proteins During Weight Reduction
Tzotzas, T., Dumont, L., Triantos, A. A., Karamouzis, M., Constantinidis, T. C., & Lagrost, L. (2006) · Obesity · doi:10.1038/oby.2006.119 · Cited by 32
“Finally, putative alterations in plasma lipid transfer proteins might bring about new insight into the reductions of cardiovascular risk markers that occur in the very early phase of weight loss (13).”
BackgroundYoong, S. L., Carey, M. L., Sanson‐Fisher, R., D’Este, C. A., Mackenzie, L., & Boyes, A. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2637-4 · Cited by 30
Tardy, A.-L., Giraudet, C., Rousset, P., Rigaudière, J., Laillet, B., Chalançon, S., Salles, J., Loreau, O., Chardigny, J., & Morio, B. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700561-jlr200 · Cited by 34
Amin, M., Kerr, D. C., Atiase, Y., Aldwikat, R. K., & Driscoll, A. L. (2023) · Sports · doi:10.3390/sports11050101 · Cited by 35
Obesity, Weight Loss, and Employment Prospects: Evidence from a Randomized Trial
Reichert, A. R. (2015) · The Journal of Human Resources · doi:10.3368/jhr.50.3.759 · Cited by 27
Harrold, J. A., & Halford, J. C. G. (2006) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488906778773616 · Cited by 27
“Despite the resistance of obesity to treatment, numerous trials and weight loss interventions have demonstrated that modest weight loss and continued weight control confer sustainable improvements in health [8,9].”
BackgroundThe Effect of Dietary Glycemic Index on Weight Maintenance in Overweight Subjects: A Pilot Study
Philippou, E., Neary, N. M., Chaudhri, O. B., Brynes, A. E., Dornhorst, A., Leeds, A., Hickson, M., & Frost, G. S. (2008) · Obesity · doi:10.1038/oby.2008.533 · Cited by 31
“A 5–10% body weight loss reduces obesity complications and risks substantially while weight maintenance is imperative for sustaining these benefits (1).”
BackgroundMaston, G., Gibson, A. A., Kahlaee, H. R., Franklin, J., Manson, E., Sainsbury, A., & Markovic, T. (2019) · Behavioral Sciences · doi:10.3390/bs9120144 · Cited by 30
Pramlintide in the treatment of diabetes
Edelman, S. V., Darsow, T., & Frías, J. P. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01187.x · Cited by 22
The Effect of Maternal Employment on Youth Overweight in Australia*
Bishop, J. (2011) · Economic Record · doi:10.1111/j.1475-4932.2011.00747.x · Cited by 22
Kuate, D., Etoundi, B. C., Ngondi, J. L., & Oben, J. E. (2010) · Food Research International · doi:10.1016/j.foodres.2010.09.037 · Cited by 24
“Weight reduction is associated with favorable changes in cardiovascular risk factors (Vidal, 2002).”
BackgroundAlkharaiji, M. A., Anyanwagu, U., Donnelly, R., & IDRIS, I. R. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03809-4 · Cited by 22
De Vet, E., Nelissen, R. M., Zeelenberg, M., & De Ridder, D. T. (2013) · Journal of Health Psychology · doi:10.1177/1359105312454038 · Cited by 22
“Weight reductions of just 5%–10% result in significantly fewer health risks associated with excess body weight (Vidal, 2002).”
BackgroundCurrent Perspectives on Long-term Obesity Pharmacotherapy
Wharton, S. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.07.005 · Cited by 30
Strategies for Weight Reduction Prior to Total Joint Arthroplasty
Chen, M. J., Bhowmick, S., Beseler, L., Schneider, K. L., Kahan, S. I., Morton, J. M., Goodman, S. B., & Amanatullah, D. F. (2018) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.18.00020 · Cited by 21
Ostendorf, D. M., Blankenship, J. M., Grau, L., Arbet, J., Mitchell, N. S., Creasy, S. A., Caldwell, A. E., Melanson, E. L., Phelan, S., Bessesen, D. H., et al. (2021) · Obesity Science & Practice · doi:10.1002/osp4.530 · Cited by 23
“This racial difference in short‐term weight loss is especially troubling considering that Black adults have higher rates of obesity and obesity‐related comorbidities such as diabetes and cardiovascular disease,(31) and even short‐term weight loss can have beneficial effects on cardiometabolic risk.(32) These racial di…”
BackgroundOperative Techniques to Reduce Hip and Knee Arthroplasty Complications in Morbidly Obese Patients
Rankin, K. A., Gibson, D., Schwarzkopf, R. M., O’Connor, M. I., & Wiznia, D. H. (2022) · Arthroplasty Today · doi:10.1016/j.artd.2022.07.016 · Cited by 25
“Instead, weight loss as a percent of body mass is an evidence-based option to consider: Weight loss of as little as 5% can lead to clinically meaningful improvements in the patient’s metabolic profile (eg, glucose and lipid levels) [46,47] and has been found to reduce surgical complications [43,45,47e49].”
BackgroundMovement Is Life—Optimizing Patient Access to Total Joint Arthroplasty: Obesity Disparities
Sabesan, V. J., Rankin, K. A., & Nelson, C. L. (2022) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-21-00424 · Cited by 20
Metadata
- Authors
- Vidal, J.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Corresponding author
- Vidal, J
- ORCID
- Vidal, J
- Venue
- International Journal of Obesity
- Published
- 2002-11-28
- Volume
- 26
- Issue
- S4
- Pages
- S25-S28
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W1982526347
- Cited by
- 188
- References
- 0
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 4 · 2023: 6 · 2022: 8 · 2021: 9 · 2020: 11 · 2019: 9 · 2018: 8 · 2017: 9 · 2016: 9 · 2015: 10 · 2014: 9 · 2013: 9 · 2012: 9
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
- Keywords
- weight loss, obesity, type 2 diabetes, hypertension, hyperlipidemia, cardiovascular risk factors, risk factor clustering, lifestyle intervention, weight loss maintenance
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypertension, Obesity, Weight Loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.